# RF Bio breaks ground on HA filler and botulinum toxin plant in Wonju, South Korea

RF Bio, a subsidiary of RF Tech, held a groundbreaking ceremony on October 28, 2022, for a new plant in Wonju, South Korea, to produce hyaluronic acid fillers and botulinum toxin. The company is investing approximately KRW 33.1 billion (USD 23 million) in the facility, which is expected to be completed by December 2023 and will increase production capacity fivefold by 2024.

- Type: New facility
- Announced: 2022-10-28
- Where: Wonju, South Korea, South Korea
- Value: $23.0M (33.1B KRW)
- Starts operating: 2024
- Status: under construction
- Capacity: 5 times current capacity
- Products: hyaluronic acid fillers, botulinum toxin, skin boosters
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [RF Bio](https://endata.com/companies/66213.md)
- [RF Tech](https://endata.com/companies/66214.md) (partner)

## Sources

- [pharmnews.com](https://www.pharmnews.com/news/articleView.html?idxno=212571), 2022-10-28: "현재 군포공장에서는 증가하는 국내외 미용·의료기기 수요에 대응하기 어렵다고 판단해 선제적 투자를 통해 최신 설비를 갖춘 신공장을 건설하게 됐다"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.